Saudi Arabia Drug Patents

« Back to Dashboard

Drug Patents in Saudi Arabia and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Document Number	Estimated Expiration	Equivalent US Patent	US Expiry Date	Generic Name	US Applicant	US Tradename
988	➤ Try a Free Trial	5929028	Jan 14, 2018	follitropin alfa/beta	Organon Usa Inc	FOLLISTIM AQ
503	➤ Try a Free Trial	6087380	Dec 28, 2021	dabigatran etexilate mesylate	Boehringer Ingelheim	PRADAXA
1164	➤ Try a Free Trial	6096742	Jul 1, 2018	aprepitant	Merck	EMEND
Document Number	Estimated Expiration	Equivalent US Patent	US Expiry Date	Generic Name	US Applicant	US Tradename

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.